oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]
AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.
Simple blood test shows promise to detect multiple cancers and tissue origin / 13 days
Harold P. Freeman, patient‑navigation pioneer, dies at 93 / 6 days
Countdown to Brachytherapy Awareness Day spotlights the specialty / 2 months
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 5 months
National study to use genetic testing to guide cancer survivor follow-up / 3 months
Bowelbabe Fund reaches £20M and announces vaccine initiative / 4 months
Air pollution causes detectable blood changes years before lung cancer / 15 days
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.